What’s ahead for Eli Lilly and Novo as RFK Jr. takes over HHS
by Contributor since / Followers
2 months ago
Andrew Harnik/Getty Images News
Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the Department of Health
